Morningstar
•
Oct 30, 2026
DexCom, Inc.: DexCom Earnings: Smooth Sailing Signals Full Recovery From 2025
Summary
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Market Update: CB, F, FLEX, ISRG, TSCO, VZ
Oct 30, 2026
•
VZ, F, FLEX, TSCO, ISRG, CB
Analyst Report: Intuitive Surgical Inc
Oct 30, 2026
•
ISRG
Analyst Report: Illumina, Inc.
Oct 29, 2026
•
ILMN
Analyst Report: Align Technology, Inc.
Oct 29, 2026
•
ALGN
Technical Assessment: Bullish in the Intermediate-Term
Oct 29, 2026
•
ILMN, MS
Analyst Profile
Debbie S. Wang
Senior Equity Analyst
Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald/s, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.
